13F HOLDINGS REPORT
TCG Crossover Management, LLC
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001214659-23-014945
Total Value
$679.1M
Positions
26
Other Managers
0
Confidential Omitted
No
Holdings (26)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | STRUCTURE THERAPEUTICS INC | GPCR | 1,502,747 | $75.8M | 11.16% |
| 2 | COGENT BIOSCIENCES INC | COGT | 5,631,042 | $54.9M | 8.08% |
| 3 | GERON CORP | GERN | 23,375,839 | $49.6M | 7.30% |
| 4 | AN2 Therapeutics, Inc. | ANTX | 2,678,209 | $43.1M | 6.34% |
| 5 | SAVARA INC. | SVRA | 10,000,000 | $37.8M | 5.57% |
| 6 | TAYSHA GENE THERAPIES, INC. | TSHA | 11,111,111 | $35.1M | 5.17% |
| 7 | KALVISTA PHARMACEUTICALS, INC | KALV | 3,395,495 | $32.7M | 4.81% |
| 8 | INHIBRX,INC | INBX | 1,750,387 | $32.1M | 4.73% |
| 9 | AEROVATE THERAPEUTICS INC | 008064107 | 2,201,274 | $29.9M | 4.40% |
| 10 | Icosavax, Inc. | 45114M109 | 3,703,704 | $28.7M | 4.23% |
| 11 | COMPASS PATHWAYS PLC | CMPS | 3,858,000 | $28.5M | 4.20% |
| 12 | VENTYX BIOSCIENCES, INC | 92332V107 | 815,724 | $28.3M | 4.17% |
| 13 | TYRA BIOSCIENCES INC | TYRA | 1,989,103 | $27.4M | 4.03% |
| 14 | MADRIGAL PHARMACEUTICALS INC | MDGL | 179,917 | $26.3M | 3.87% |
| 15 | SILENCE THERAPEUTICS PLC | SLNCF | 2,104,875 | $20.7M | 3.04% |
| 16 | TARSUS PHARMACEUTICALS, INC. | TARS | 1,142,857 | $20.3M | 2.99% |
| 17 | RAYZEBIO, INC. | 75525N107 | 869,908 | $19.3M | 2.84% |
| 18 | DYNE THERAPEUTICS, INC | DYN | 1,650,150 | $14.8M | 2.18% |
| 19 | CENTESSA PHARMACEUTICALS PLC | CNTA | 2,040,816 | $13.2M | 1.94% |
| 20 | KURA ONCOLOGY INC | KURA | 1,423,642 | $13.0M | 1.91% |
| 21 | IMMUNOVANT, INC | IMVT | 334,853 | $12.9M | 1.89% |
| 22 | ENTRADA THERAPEUTICS INC | TRDA | 584,955 | $9.2M | 1.36% |
| 23 | GRACELL BIOTECHNOLOGIES INC. | 38406L103 | 3,038,889 | $8.8M | 1.29% |
| 24 | CABALETTA BIO, INC | CABA | 486,795 | $7.4M | 1.09% |
| 25 | MERUS N.V. | N5749R100 | 300,000 | $7.1M | 1.04% |
| 26 | C4 THERAPEUTICS, INC. | CCCC | 1,276,574 | $2.4M | 0.35% |